医学
替代医学
医学物理学
家庭医学
传统医学
病理
作者
Lanying Liu,Jianjun Wang,Wei Shan Li,Jing Gao,Wangtao Li,Yan Li,Liyuan Luo,Li-Yuan Guo,Yiying Hu,Yongjun Chen,Hongyan Chen,Yu Lin,Bin Fen,Hongxiao Jia,Zhang‐Jin Zhang,Zhaojun Yan,Wei Qiu Chen,Zhangsheng Yu,Zhen Wang
标识
DOI:10.1136/gpsych-2024-101747
摘要
Depressive disorders are mental illnesses that seriously affect public health. There are approximately 320 million patients with depression worldwide, accounting for 4.4% of the total disease burden. 1 Depression leads to social and occupational impairment, diminished quality of life and an elevated risk of death by suicide. The Global Burden of Disease 2019 study indicated that depression is the second leading medical cause of disability worldwide.2 Despite advances in treatment, several challenges remain in the clinical management of depression, particularly the relatively low response rates among older adults and younger individuals.3 The delayed efficacy of commonly prescribed antidepressants (ADs) poses a risk of inadequate control over suicidal tendencies. Moreover, the numerous adverse reactions associated with ADs, particularly during the initial stages of treatment, significantly impact patient adherence.4
科研通智能强力驱动
Strongly Powered by AbleSci AI